【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Relapsed Acute Myeloid Leukemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Relapsed Acute Myeloid Leukemia to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Relapsed Acute Myeloid Leukemia to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Relapsed Acute Myeloid Leukemia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Relapsed Acute Myeloid Leukemia Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Relapsed Acute Myeloid Leukemia 33
Aug 28, 2013: Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study 33
Jun 25, 2013: FDA Issues Partial Clinical Hold On Cell Therapeutics’s Tosedostat For Treatment Of Blood Cancer 33
Jun 13, 2013: Sunesis Pharma Announces Data And Safety Monitoring Board Recommends Continuation Of VALOR Trial With No Change To Study Conduct 33
Apr 01, 2013: Clavis Pharma Reports Negative Outcome Of Phase III CLAVELA Trial With Elacytarabine In Patients With Acute Myeloid Leukemia 34
Nov 28, 2012: Coronado Biosciences Initiates Phase I/II Trial Of CNDO-109 Activated Allogeneic Natural Killer Cells In Acute Myeloid Leukemia 34
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Sanofi 39
Clinical Trial Overview of Sanofi 39
C. H. Boehringer Sohn AG & Co. KG 40
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 40
Ambit Biosciences Corporation 41
Clinical Trial Overview of Ambit Biosciences Corporation 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Chroma Therapeutics Ltd. 43
Clinical Trial Overview of Chroma Therapeutics Ltd. 43
Celator Pharmaceuticals, Inc. 44
Clinical Trial Overview of Celator Pharmaceuticals, Inc. 44
AROG Pharmaceuticals LLC 45
Clinical Trial Overview of AROG Pharmaceuticals LLC 45
Amgen Inc. 46
Clinical Trial Overview of Amgen Inc. 46
Clinical Trial Overview of Top Institutes / Government 47
National Cancer Institute 47
Clinical Trial Overview of National Cancer Institute 47
Fred Hutchinson Cancer Research Center 50
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 50
The University of Texas M. D. Anderson Cancer Center 52
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 52
Children’s Oncology Group 53
Clinical Trial Overview of Children’s Oncology Group 53
Washington University School of Medicine 54
Clinical Trial Overview of Washington University School of Medicine 54
Stanford University 55
Clinical Trial Overview of Stanford University 55
Roswell Park Cancer Institute 56
Clinical Trial Overview of Roswell Park Cancer Institute 56
University of California, San Francisco 57
Clinical Trial Overview of University of California, San Francisco 57
Case Comprehensive Cancer Center 58
Clinical Trial Overview of Case Comprehensive Cancer Center 58
Five Key Clinical Profiles 59
Appendix 116
Abbreviations 116
Definitions 116
Research Methodology 117
Secondary Research 117
About GlobalData 118
Contact Us 118
Disclaimer 118
Source 119
【レポート販売概要】
■ タイトル：再発急性骨髄白血病：グローバル臨床試験レビュー（2014年上半期）■ 英文：Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014
■ 発行日：2014年4月24日
■ 調査会社：GlobalData
■ 商品コード：GDHC2099CTIDB
■ 調査対象地域：グローバル
- クラウド侵入検知・防止システム（IDP）の世界市場2016-2020About Cloud Intrusion Detection and Prevention Increasing cases of cyber attacks have compelled enterprises to increase their spending on IT infrastructure to prevent theft of data. IDSs identify malicious activities over the network and intrusion prevention systems (IPSs) prevent data modification or unauthorized access. IDSs and IPSs include hardware, software, and services. IDS is a passive mon …
- グローバル・マネー・ローンダリング対策(AML)ソフトウェア市場（2014-2018）About Anti-money Laundering (AML) Software AML software is used by financial institutions to detect suspicious transactions and analyze customer data. AML software operates under various categories including currency transaction report, customer identity management, transaction monitoring systems, and compliance software. AML solutions provide real-time alerts and tools for financial enterprises t …
- 3Dマシンビジョンの世界市場予測（～2022）The 3D machine vision market is expected to be valued at USD 2.13 Billion by 2022, growing at a CAGR of 11.07% between 2017 and 2022. Some of the key factors driving the growth of this market are integration of 3D vision systems with robot controllers, rising demand for 3D object analyses in manufacturing applications, and increasing demand for non-industrial 3D machine vision systems. 3D machine …
- 生体認証技術の世界市場分析：用途別（顔、掌形、音声、サイン、虹彩、AFIS、非AFIS）、エンドユーザー別（政府、銀行及び金融、消費者家電、ヘルスケア、防衛･保安）、地域別、セグメント予測、2014-2025The global biometrics technology market is expected to reach USD 59.31 billion by 2025, according to a new study by Grand View Research, Inc. The increasing demand for biometrics technology across various applications is expected to favor the market growth over the next nine years. Biometrics technology is used by several verticals in private, public, and commercial sectors to overcome security th …
- セラミック膜の世界市場：チタニア、アルミナ、酸化ジルコニウムCeramic membranes are defined as a chemically, mechanically, and thermally stable material having higher permeance and low membrane resistance as compared to polymeric membranes. They have the capability to provide mild, highly selective filtration process with high flux and without phase transformation and possess specific functional attributes. Ceramic membranes are used for engineering applicat …
- 高度教育用金融・HRMソフトウェアの世界市場2016-2020About the Higher Education Financial and HRM Software Market The global higher education financial and HRM software market consists of software solutions that are employed by institutions to improve the decision-making and productivity of employees and management of financial resources. The data collected from the software is further analyzed using analytics applications. The analysis is to ensure …
- 世界における小型自動車用安全システム市場（2008-2028）This latest just-auto report edition offers a global review of the OE active and passive safety systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE active and passive safety systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major pl …
- 日本の分子診断・検査市場2014This report provides an overview of the Japanese molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.Table of ContentsBusiness Environment Market Structure Market Size, Growth, and Major Suppliers' Market Shares List of TablesMole …
- Carnarvon Petroleum Limited：石油・ガスの開発・生産動向及びコスト分析- 2012Carnarvon Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Carnarvon Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- 世界の風疹検査市場The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerc …
- バルーン椎骨形成の世界市場2015-2019About Balloon Kyphoplasty VCF is characterized by the collapse of one or more vertebral bodies, resulting in persistent and unbearable pain in patients. Osteoporosis, a degenerative bone disease, is a leading cause of VCF among elderly women. Metastatic bone disease, multiple myeloma, metastatic spinal tumors, and traumatic injuries also cause VCF. Individuals with VCF can undergo vertebroplasty a …
- 自動販売機の世界市場2015-2019About vending machine A vending machine is used to dispense products such as beverages, snacks, lottery tickets, cigarettes, and other consumer goods after inserting required amount into the machine. Vending machine is used in the automatic retailing industry. Modernized vending machines are available with many technologies such as interactive displays, cashless payment options, and telemetry syst …
- 自動車先進運転支援システム（ADAS）の世界市場：用途別、技術別、地域別Global Automotive Advanced Driver Assistance System (ADAS) Market: About this market Technavio’s automotive ADAS market analysis considers sales from both passenger cars and commercial vehicle applications. Our study also finds the sales of automotive ADAS in APAC, Europe, MEA, North America, and South America. In 2019, the passenger car segment had a significant market share, and this trend is ex …
- Twin Butte Energy Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Twin Butte Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Twin Butte Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 世界のヘモフィリア市場：Global Hemophilia Market 2014-2018TechNavio's analysts forecast the Global Hemophilia market to grow at a CAGR of 6.07 percent over the period 2013-2018. One of the key factors contributing to this market growth is the development of new hemophilia therapeutics. The Global Hemophilia market has also been witnessing the increase in technological innovations. However, the high cost of hemophilia therapeutics could pose a challenge t …
